Keros Therapeutics, Inc. Insider Transactions
Keros Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Pontifax Management 4 G.P. (2015) Ltd.
10 percent owner |
Sell | 155,262 @ $17.75 | $2.76 M | 0 | 10/15/2025 | 10/17/2025 | |
|
ADAR1 Capital Management, LLC
10 percent owner |
Sell | 743,358 @ $17.75 | $13.19 M | 0 | 10/15/2025 | 10/15/2025 | |
|
ADAR1 Capital Management, LLC
10 percent owner |
Buy | 74,333 @ $10.33 | $767.86 K | 4,392,737 | 04/09/2025 | 04/11/2025 | |
|
ADAR1 Capital Management, LLC
10 percent owner |
Buy | 500,000 @ $10.33 | $5.17 M | 4,318,404 | 04/09/2025 | 04/11/2025 | |
|
ADAR1 Capital Management, LLC
10 percent owner |
Buy | 325,000 @ $9.86 | $3.20 M | 3,818,404 | 04/09/2025 | 04/11/2025 | |
|
ADAR1 Capital Management, LLC
10 percent owner |
Buy | 18,560 @ $9.40 | $174.38 K | 3,493,404 | 04/09/2025 | 04/11/2025 | |
|
ADAR1 Capital Management, LLC
10 percent owner |
Buy | 16,365 @ $9.40 | $153.75 K | 743,558 | 04/09/2025 | 04/11/2025 | |
|
GORDON CARL L
Director |
Sell | 220,600 @ $44.01 | $9.71 M | 899,212 | 08/13/2024 | 08/15/2024 | |
|
GORDON CARL L
Director |
Sell | 29,400 @ $44.01 | $1.29 M | 119,522 | 08/13/2024 | 08/15/2024 | |
|
ORBIMED ADVISORS LLC
Director |
Sell | 220,600 @ $44.01 | $9.71 M | 899,212 | 08/13/2024 | 08/15/2024 | |
|
ORBIMED ADVISORS LLC
Director |
Sell | 29,400 @ $44.01 | $1.29 M | 119,522 | 08/13/2024 | 08/15/2024 | |
|
Regnante Keith
CHIEF FINANCIAL OFFICER |
Sell | 40,000 @ $45.29 | $1.81 M | 0 | 01/04/2024 | 01/24/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Keros Therapeutics, Inc. FAQ's
The list of insiders at Keros Therapeutics, Inc. includes ADAR1 Capital Management, LLC, Pontifax Management 4 G.P. (2015) Ltd..
Insiders have sold a total of 898.62 K Keros Therapeutics, Inc. shares in the last 12 months for a total of 15.95 M sold.
The following insiders have sold Keros Therapeutics, Inc. shares in the last 12 months: Pontifax Management 4 G.P. (2015) Ltd. ($2.76 M), ADAR1 Capital Management, LLC ($13.19 M),
Insiders have purchased a total of 934.26 K Keros Therapeutics, Inc. shares in the last 12 months for a total of 9.46 M.
The following insiders have purchased Keros Therapeutics, Inc. shares in the last 12 months: ADAR1 Capital Management, LLC ($9.46 M),